Table 1 Relationship between IGF2R expression and clinicopathological factors in patients with cervical cancer.

Age (years)

 <50

182

2,739

0.209

 ≥50

123

2,950

Histological type 1

 Squamous cell carcinoma

258

2,834

0.777

 Adenocarcinoma

47

2,768

Histological type 2

 Keratinizing

55

3,086

0.14

 Non-keratinizing

119

2,756

Lymph node status

 No metastasis

130

2,724

0.716

 Metastasis

71

2,652

Distal metastasis

 No metastasis

135

2,657

0.202

 Metastasis

21

3,190

Primary therapy outcome

 CR/PR

141

2,947

0.551

 SD/PD

24

3,149

TMN staging

 Stage I

161

2,678

0.032

 Stage II–IV

137

3,027

TMN staging

 Stage I

161

2,678

-

 Stage II

69

2,991

 Stage III

46

2,854

 Stage IV

22

3,501